17:56 IST
BSE
Board Meeting Date
Natco Pharma Board Meeting Date
Natco Pharma will hold a board meeting on 25th September 2026 to finalise terms for its previously approved rights issue, including pricing and record date.
Natco Pharma Ltd
- Share price
- ₹810.90
- Market cap
- ₹15,907 Cr
- Revenue (annual)
- ₹4,078 Cr
- Net profit (annual)
- ₹1,418 Cr
- P/E (TTM)
- 13.9×Sector 47.4×
- Promoter holding
- 49.42%+0.00% QoQ
- FII holding
- 16.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 6Board Meeting Date 4Financial Results 3Capital Structure Change 3Board Meeting Outcome 3Regulatory Approval 2Other Announcement 2Legal & Regulatory 2Fund Raise 2Acquisition 2Promoter Selling (Off-Market) 1Merger & Restructuring 1Management Change 1Dividend 1Business Update 1Annual Report 1Annual General Meeting 1
Time
4 announcements with these filters
19:06 IST
NSE
Board Meeting Date
Natco Pharma Board Meeting Date
Natco Pharma Limited has scheduled a board meeting for September 9, 2026, to discuss potential fund-raising proposals.
16:50 IST
BSE
Board Meeting Date
Natco Pharma Board Meeting Date
Natco Pharma has scheduled a board meeting on August 14, 2026, to consider its quarterly financial results and a potential interim dividend.
16:38 IST
BSE
Board Meeting Date
Natco Pharma Board Meeting Date
Natco Pharma scheduled a board meeting for May 29, 2026, to approve fiscal year financial results. The trading window remains closed for designated persons.